FOXP3, or forkhead box protein P3, is a transcription factor that controls gene activity essential to the development and function of regulatory T cells (Tregs). These cells restrain responses of the immune system and help prevent autoimmunity, in which immune responses damage the body’s own tissues. The name denotes both the protein and its encoding gene. Pathogenic variants in the human gene cause a rare inherited disorder, IPEX syndrome, demonstrating the importance of FOXP3-dependent regulation to normal immune function. (medlineplus.gov)
Gene and protein structure
The human FOXP3 gene lies at Xp11.23 on the X chromosome. It encodes a member of the forkhead, or winged-helix, family of transcriptional regulators. Alternative splicing produces transcripts encoding different protein isoforms. Human gene nomenclature uses italicized FOXP3, whereas the corresponding mouse gene is written Foxp3. (ncbi.nlm.nih.gov)
FOXP3 contains a forkhead domain that binds DNA, together with zinc-finger and leucine-zipper regions involved in its molecular organization. Structural experiments have examined both the zinc-finger–leucine-zipper region and complexes containing the forkhead domain, DNA, and the transcription factor NFAT1. These studies show that FOXP3 function involves protein–protein interactions as well as recognition of DNA sequences. It therefore operates within molecular complexes rather than as an isolated switch controlling every Treg-associated gene. (pubmed.ncbi.nlm.nih.gov)
Role in regulatory T cells
FOXP3 is closely associated with the regulatory subset of CD4-positive T cells. Many of these cells develop in the thymus and express high levels of CD25, the alpha chain of the interleukin-2 receptor. Their suppressive activity contributes to immune tolerance, particularly peripheral immune tolerance, by limiting responses of potentially self-reactive lymphocytes. Experimental introduction of Foxp3 into naive mouse T cells can redirect them toward a regulatory phenotype, establishing a causal role beyond its usefulness as a marker. (medlineplus.gov)
The requirement for Foxp3 continues after Treg development. In conditional mouse experiments, deleting Foxp3 from mature regulatory cells caused loss of suppressive function and enabled production of interleukin-2 and inflammatory cytokines. The cells also showed altered expression of Foxp3 target genes. Thus, continued expression maintains an established regulatory program rather than merely initiating differentiation once. These findings distinguish the formation of a cell population from the mechanisms needed to preserve its functional identity. (pubmed.ncbi.nlm.nih.gov)
Regulation and stable expression
FOXP3 expression is regulated by extracellular signals and regulatory DNA elements. Interleukin-2 supports human Treg FOXP3 expression through STAT-dependent signaling. In mouse Tregs, a conserved intronic element called CNS2 helps preserve Foxp3 expression during cell division, especially when interleukin-2 is limiting. CNS2 also counteracts signals that would otherwise destabilize expression during inflammation. It links environmental signaling to the inheritance of regulatory-cell identity. (pubmed.ncbi.nlm.nih.gov)
DNA methylation provides another level of regulation. Human studies have identified distinctive demethylation patterns at the FOXP3 locus in committed Tregs, associated with stable expression and suppressive function. Genome-wide experiments additionally found that methylation at target loci can influence access by FOXP3 to DNA. These observations place FOXP3 within a broader epigenetic program: the presence of the protein and the accessibility of its regulatory targets are related but separate features. (pubmed.ncbi.nlm.nih.gov)
Human disease
Pathogenic mutations in FOXP3 cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, abbreviated IPEX. The disorder involves autoimmune abnormalities affecting the intestines, skin, and endocrine organs. Variants may disrupt the DNA-binding region or produce an abnormally shortened protein, impairing normal regulatory-cell function. The connection between human FOXP3 mutations and IPEX was established through genetic studies published in 2001. (medlineplus.gov)
FOXP3-associated disease cannot always be described simply as an absence of Tregs. Studies of patients have found heterogeneous abnormalities: some retain cells with regulatory-associated surface markers or detectable FOXP3 protein, but those cells do not function normally in all experimental conditions. Consequently, protein detection, cell abundance, and suppressive capacity are distinct measurements. A pathogenic variant can affect function without eliminating every phenotypic feature associated with the regulatory population. (pubmed.ncbi.nlm.nih.gov)
Discovery and interpretation as a marker
A major step in FOXP3 research came from the scurfy mouse, an X-linked mutant with severe lymphoproliferation and multiorgan immune infiltration. In 2001, investigators identified the defective gene as Foxp3 and named its protein product scurfin. The mutation produced a protein lacking the forkhead domain; genetic complementation demonstrated its importance for immune homeostasis. Research published in 2003 then directly connected Foxp3 to regulatory T-cell development. (pubmed.ncbi.nlm.nih.gov)
FOXP3 is a valuable Treg-associated marker, but its interpretation differs between experimental settings. Activated conventional human T cells can express FOXP3 transiently without acquiring suppressive activity. Another human study found that transforming growth factor beta induced substantial FOXP3 expression without producing a regulatory phenotype. FOXP3 positivity alone therefore does not establish that a human cell is a committed, functional Treg. Expression history, methylation patterns, and functional assays provide complementary evidence, especially in activated or cultured cell populations. (pubmed.ncbi.nlm.nih.gov)